The largest database of trusted experimental protocols

Sh sy5y

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom

SH-SY5Y is a neuroblastoma cell line derived from a metastatic bone tumor. It is commonly used in research as a model for studying neurological diseases and processes. The cell line exhibits characteristics of immature sympathetic neurons.

Automatically generated - may contain errors

96 protocols using sh sy5y

1

In vitro Parkinson's Disease Model with SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human neuroblastoma cell line SH-SY5Y (ATCC Cat. CRL-2266) was cultured in Dulbecco’s minimum essential medium (DMEM) (Corning®, Corning, NY, USA) supplemented with glutamine and antibiotics. Differentiated SH-SY5Y cells are broadly accepted for in vitro studies requiring neuronal-like cells. Differentiated SH-SY5Y cells are low-cost to culture, and the ethical concerns related to primary human neuronal culture are avoided. Moreover, since SH-SY5Y cells are human-derived, they express several human-specific proteins and isoforms that would not be inherently present in rodent primary cultures [25 (link),26 (link)]. To induce the differentiation, SH-SY5Y were plated at 15,000 cells/cm2 and after 24 h were grown in 10 μM Retinoic acid (RA) (Sigma, St. Louis, MO, USA) with 1% FBS for 3 days. After 3 days, the media were replaced with fresh 12-O-tetradecanoylphorbol-13-acetate (TPA) (Sigma, USA) for another 3 days of differentiation. For the setup of the in vitro Parkinson’s disease model, the SH-SY5Y cells line was treated with 6-OHDA (Sigma, USA) (ranging from 25 µM to 100 µM) for 24 h after differentiation [27 (link)]. The treatments with L-methionine and taurine (Dompé Farmaceutici, Milano, Italy), ranging from of 0.1 mg/mL to 5 mg/mL, were performed one hour before 6-OHDA stress.
+ Open protocol
+ Expand
2

Modulating α-Synuclein Aggregation in Human Neuroblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma cells (SH-SY5Y cells) were purchased from Procell Life Science & Technology Co., Ltd. SH-SY5Y cells were cultured in MEM/F12 (Gibco) containing 10% foetal bovine serum and 1% penicillin/streptomycin, hereafter referred to marked as SH-SY5Y medium. The cells were maintained at 37 °C in an atmosphere of 5% carbon dioxide and 95% humidity. The induction medium consisted of SH-SY5Y medium supplemented with MPP+(D048, Sigma‒Aldrich) at a concentration of 5 μM. To establish a α-Syn pathological aggregation cell model, we first cultured SH-SY5Y cells on cell culture dishes or coverslips with SH-SY5Y medium for 24 h. Next, we aspirated the original SH-SY5Y medium, washed the cells with PBS, and added an equal volume of induction medium to obtain the induced treatment group. The control group was obtained in a similar way but the SH-SY5Y medium was replaced with fresh SH-SY5Y medium, not induction medium.
+ Open protocol
+ Expand
3

Stimulating IP3 Release in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To stimulate IP3 release and thus IP3R, cells were treated with bradykinin (fibroblasts) or carbachol (SH-SY5Y). Prior to stimulation, cells underwent serum starvation. For this, cells were first washed in PBS (Sigma) and then cultured for 4 hours in DMEM (fibroblasts; Thermo Fisher Scientific) or DMEM/F12 (SH-SY5Y; Thermo Fisher Scientific) without FBS. Afterwards cells were treated with 300 nm bradykinin (fibroblasts; B3259, Sigma, powder dissolved in ddH2O) or 1 mm carbachol (SH-SY5Y; C4382, Sigma, dissolved in ddH2O) in the respective culture medium for t = 0, 30, 60 min (fibroblasts) or t = 0, 2, 4 h (SH-SY5Y). After treatment, cells were washed in PBS and scraped in adioimmunoprecipitation assay (RIPA) buffer (Sigma) including protease inhibitor (cOMPLETE Mini, Roche Applied Sciences) (fibroblasts) or PBS (SH-SY5Y). Immunoblots were then performed as described above.
+ Open protocol
+ Expand
4

Δ8-THC Treatment of Differentiated SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SH-SY5Y cell line was acquired from American Type Culture Collection (ATCC) (Manassas, VA, USA). We grew the human neuroblastoma cell line SH-SY5Y in a monolayer at 37 °C in a 5% CO2 humidified atmosphere using Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 Ham (DMEM/F12) medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich), 1% glutamine and 1% penicillin-streptomycin (100 U-100 µg/mL). To induce neuronal differentiation of SH-SY5Y cells, we incubated them for 5 days with 10 µM of all-trans RA (Sigma-Aldrich) [7 (link),65 (link)]. We dissolved Δ8-THC in DMSO and then diluted in PBS. We added it in the medium at the final concentration (the final DMSO concentration was <0.1%). We treated the differentiated SH-SY5Y cells with 20 µM Δ8-THC for 24 h.
+ Open protocol
+ Expand
5

Antioxidant Evaluation in SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SH-SY5Y human neuroblastoma cell line was purchased from CLS (Cell Lines Service GmbH, Eppelheim, Germany). Cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS, Sigma-Aldrich, St. Louis, MO, USA), 100 IU/mL penicillin G, 100 μg/mL streptomycin, 1% L-glutamine, 1% non-essential amino acids, without sodium pyruvate at 37 °C in 5% CO2-humidified atmosphere. At the time of 85% confluence the cells were subcultured, and the medium was changed every 3–4 days. For cell differentiation, SH-SY5Y cells were switched to a DMEM/F12 medium supplemented with 1% FBS in presence of 80 nM phorbol 12-myristate, 13 acetate (PMA, Sigma-Aldrich) for at least 6 days and the actual differentiation was evaluated by the observation of neurites outgrow by microscopy and the evaluation of βIII-tubulin mRNA levels by real-time PCR. Oxidative stress was induced by treating undifferentiated or differentiated SH-SY5Y cells with 10 μM catechol (Sigma-Aldrich). All the synthesized compounds as well as a reference antioxidant, Trolox (TRX, Sigma-Aldrich), were used at a concentration of 10 μM.
+ Open protocol
+ Expand
6

Culture and Maintenance of SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma cell‐line SH‐SY5Y (Sigma‐Aldrich, St. Louis, MO, USA) was thawed and seeded out in Poly‐l‐lysine (Sigma‐Aldrich, St. Louis, MO, USA) coated 12‐well plates (Nunc, Thermo Fisher Scientific, Waltham, MA) and Lab‐Tek 8‐well chamber slides (Thermo Fisher Scientific, Waltham, MA) coated with either Poly‐l‐Lysine or collagen I rat tail (Thermo Fisher Scientific, Waltham, MA). The SH‐SY5Y cells were grown in medium containing 41.5% Minimum Essential Medium Eagle (Sigma‐Aldrich, St. Louis, MO, USA), 41.5% Nutrient mixture F‐12 Ham (Sigma ‐Aldrich, St. Louis, MO, USA), 15% Fetal bovine serum (Thermo Fisher Scientific, Waltham, MA), 1% l‐glutamine (Thermo Fisher Scientific, Waltham, MA), 1% MEM non‐essential Amino Acids (Sigma‐Aldrich, St. Louis, MO, USA) at 37℃, 5% CO2 and 5% H2O until 60%–80% confluency.
+ Open protocol
+ Expand
7

Characterization of hnRNPDL Isoforms

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human HeLa (ATCC CCL-2) and SH-SY5Y (ATCC CRL-2266) cell lines were maintained in Dulbecco’s Modified Eagle Medium (DMEM) or minimum essential medium α (MEM-α) medium, respectively. Media were supplemented with 10% (v/v) Fetal Bovine Serum (FBS). Both cell lines were grown under a highly humidified atmosphere of 95% air with 5% CO2 at 37 °C. The HeLa hnRNPDL KO cell line was generated as described elsewhere3 (link). HeLa cells have been authenticated within the last 3 years by STR analysis. The HeLa and SH-SY5Y cell lines were regularly tested for the presence of mycoplasma using qPCR Detection Kit (SIGMA), and both cell lines are mycoplasma negative.
For recombinant protein expression, the genes encoding the three isoforms of hnRNPDL (hnRNPDL-1, hnRNPDL-2 and hnRNPDL-3) were inserted into pETite (Lucigen corporation) vector with a His-SUMO N-terminal tag. For subcellular localization experiments, the same genes were cloned into pEGFP-C3 (Clontech). In all the cases, the correctness of the DNA sequence was verified by sequencing.
+ Open protocol
+ Expand
8

Evaluating miR-659-3p in Neuroblastoma Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTLA-230 (kindly donated by Dr E. Bogenman, Los Angeles, USA) and SH-SY5Y (purchased from Banca Biologica and Cell Factory, Genoa, Italy) NB cell lines were cultured in RPMI 1640 medium supplemented with 10% heat inactivated FCS, 50 mg/ml streptomycin, 50 mg/ml penicillin and 2 mM glutamine (Sigma-Aldrich, Milan, Italy). The HTLA-230 cells present MYCN amplification and the SH-SY5Y cells have normal MYCN status. Both cell lines were checked for morphology, proliferation rate, mycoplasma contamination and MYCN amplification after thawing and within four passages in culture.
To evaluate the effect of miR-659-3p over-expression and suppression on gene expression, 1×106 HTLA-230 and SH-SY5Y cells were transfected with specific miR-659-3p mirVana™ mimic and inhibitor, respectively (Ambion, Life Technologies, Carlsbad, CA, USA, catalog# MC and MH 11582). Samples transfected with mirVana™ miRNA Mimic Negative Control #1 and mirVana™ miRNA Inhibitor Negative Control #1 were used as reference conditions. Transfection was performed at 20 nM miRNA concentration in OptiMEM© medium (Sigma-Aldrich), using Lipofectamin RNAiMAX© (Life Technologies), according to manufacturer's protocol. Cells were then cultured for 48 hours, checked for viability and processed for miRNA and total mRNA extraction, as described below. Transfection experiments were performed twice.
+ Open protocol
+ Expand
9

In Vitro Parkinson's Disease Modeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma cell line SH-SY5Y (ATCC, Manassas, VA, USA) was maintained in DMEM (Invitrogen, Grand Island, NY, USA) containing 10% heat-inactivated fetal bovine serum (FBS; Invitrogen) and 1% penicillin-streptomycin at 37°C in a humid incubator with 5% CO2. To produce an experimental PD model in vitro, SH-SY5Y cells were exposed to 0.25, 0.5, 1, and 2 mM MPP+ (Sigma, St. Louis, MO, USA) for 24 h or treated with 1 mM MPP+ for 6 h, 12 h, 24 h, and 48 h.
+ Open protocol
+ Expand
10

Culturing Murine Microglial and Human Neuroblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine microglia BV2 cells were a generous gift from Dr. Alba Minelli (University of Perugia, Perugia, Italy). The SH-SY5Y human neuroblastoma cells were purchased from American Type Culture Collection (ATCC CRL-2266; VA, USA). The BV2 and SH-SY5Y cells were cultured in Dulbecco’s modified Eagle’s medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (HyClone, UT, USA), 2 mM l-glutamine, 50 U/mL penicillin, and 50 μg/mL streptomycin (Sigma-Aldrich). The cells were maintained at 37 °C in a humidified atmosphere of 95% air and 5% CO2 and grown to 80% confluence. These cells were subcultured two or three times per week using 0.25% trypsin (Sigma-Aldrich).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!